GPER - Novel membrane oestrogen receptor

Clinical Science

Volumn 130, Issue 12, 2016, Pages 1005-1016

  Zimmerman, Margaret A ^a   Budish, Rebecca A ^a   Kashyap, Shreya ^a   Lindsey, Sarah H ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer; Cardiovascular; GPR30; Menopause; Metabolism; Reproduction

Indexed keywords

ESTROGEN; G PROTEIN COUPLED ESTROGEN RECEPTOR; G PROTEIN COUPLED RECEPTOR 30; SEX HORMONE; UNCLASSIFIED DRUG; ESTROGEN RECEPTOR; G PROTEIN COUPLED RECEPTOR; GPER PROTEIN, HUMAN;

ATHEROSCLEROSIS; ENVIRONMENTAL HEALTH; HEART FAILURE; HUMAN; HYPERTENSION; IN VITRO STUDY; KIDNEY DISEASE; MENOPAUSAL SYNDROME; MENOPAUSE; METABOLIC DISORDER; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; RANDOMIZED CONTROLLED TRIAL (TOPIC); REPRODUCTION; REVIEW; VASCULAR REMODELING; ANIMAL; METABOLISM;

ANIMALS; ESTROGENS; HUMANS; HYPERTENSION; KIDNEY DISEASES; RECEPTORS, ESTROGEN; RECEPTORS, G-PROTEIN-COUPLED;

EID: 84973570956     PISSN: 01435221     EISSN: 14708736     Source Type: Journal    
DOI: 10.1042/CS20160114     Document Type: Review

References (160)

1. Szego, C.M. and Davis, J.S. (1967) Adenosine 3',5'-monophosphate in rat uterus: acute elevation by estrogen. Proc. Natl. Acad. Sci. U.S.A. 58, 1711-1718
2. Migliaccio, A., Di Domenico, M., Castoria, G., de Falco, A., Bontempo, P., Nola, E. and Auricchio, F. (1996) Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol receptor complex in MCF-7 cells. EMBO J. 15, 1292-1300
3. Lantin-Hermoso, R.L., Rosenfeld, C.R., Yuhanna, I.S., German, Z., Chen, Z. and Shaul, P.W. (1997) Estrogen acutely stimulates nitric oxide synthase activity in fetal pulmonary artery endothelium. Am. J. Physiol. 273, L119-L126
4. Pietras, R.J. and Szego, C.M. (1977) Specific binding sites for oestrogen at the outer surfaces of isolated endometrial cells. Nature 265, 69-72
5. Hernandez-Perez, O., Ballesteros, L.M. and Rosado, A. (1979) Binding of 17-beta-estradiol to the outer surface and nucleus of human spermatozoa. Arch. Androl. 3, 23-29
6. Russell, K.S., Haynes, M.P., Sinha, D., Clerisme, E. and Bender, J.R. (2000) Human vascular endothelial cells contain membrane binding sites for estradiol, which mediate rapid intracellular signaling. Proc. Natl. Acad. Sci. U.S.A. 97, 5930-5935
7. Stevis, P.E., Deecher, D.C., Suhadolnik, L., Mallis, L.M. and Frail, D.E. (1999) Differential effects of estradiol and estradiol-BSA conjugates. Endocrinology 140, 5455-5458
8. Carmeci, C., Thompson, D.A., Ring, H.Z., Francke, U. and Weigel, R.J. (1997) Identification of a gene (GPR30) with homology to the G-protein-coupled receptor superfamily associated with estrogen receptor expression in breast cancer. Genomics 45, 607-617
9. Thomas, P., Pang, Y., Filardo, E.J. and Dong, J. (2005) Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology 146, 624-632
10. Aronica, S.M., Kraus, W.L. and Katzenellenbogen, B.S. (1994) Estrogen action via the cAMP signaling pathway: stimulation of adenylate cyclase and cAMP-regulated gene transcription. Proc. Natl. Acad. Sci. U.S.A. 91, 8517-8521
11. Improta-Brears, T., Whorton, A.R., Codazzi, F., York, J.D., Meyer, T. and McDonnell, D.P. (1999) Estrogen-induced activation of mitogen-activated protein kinase requires mobilization of intracellular calcium. Proc. Natl. Acad. Sci. U.S.A. 96, 4686-4691
12. Filardo, E.J., Quinn, J.A., Bland, K.I. and Frackelton, Jr, A.R. (2000) Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Mol. Endocrinol. 14, 1649-1660
13. Filardo, E., Neubig, R. and Prossnitz, E. (2014), http://www. guidetopharmacology.org/GRAC/FamilyIntroductionForward? familyId=22
14. Bologa, C.G., Revankar, C.M., Young, S.M., Edwards, B.S., Arterburn, J.B., Kiselyov, A.S., Parker, M.A., Tkachenko, S.E., Savchuck, N.P., Sklar, L.A. et al. (2006) Virtual and biomolecular screening converge on a selective agonist for GPR30. Nat. Chem. Biol. 2, 207-212
15. Dennis, M.K., Field, A.S., Burai, R., Ramesh, C., Petrie, W.K., Bologa, C.G., Oprea, T.I., Yamaguchi, Y., Hayashi, S., Sklar, L.A. et al. (2011) Identification of a GPER/GPR30 antagonist with improved estrogen receptor counter selectivity. J. Steroid. Biochem. Mol. Biol. 127, 358-366
16. Dennis, M.K., Burai, R., Ramesh, C., Petrie, W.K., Alcon, S.N., Nayak, T.K., Bologa, C.G., Leitao, A., Brailoiu, E., Deliu, E. et al. (2009) In vivo effects of a GPR30 antagonist. Nat. Chem. Biol. 5, 421-427
17. Olde, B. and Leeb-Lundberg, L.M. (2009) GPR30/GPER1: searching for a role in estrogen physiology. Trends Endocrinol. Metab. 20, 409-416
18. Lindsey, S.H., da Silva, A.S., Silva, M.S. and Chappell, M.C. (2013) Reduced vasorelaxation to estradiol and G-1 in aged female and adult male rats is associated with GPR30 downregulation. Am. J. Physiol. Endocrinol. Metab. 305, E113-E118
19. Cheng, S.B., Dong, J., Pang, Y., LaRocca, J., Hixon, M., Thomas, P. and Filardo, E.J. (2014) Anatomical location and redistribution of G protein-coupled estrogen receptor-1 during the estrus cycle in mouse kidney and specific binding to estrogens but not aldosterone. Mol. Cell Endocrinol. 382, 950-959
20. Jala, V.R., Radde, B.N., Haribabu, B. and Klinge, C.M. (2012) Enhanced expression of G-protein coupled estrogen receptor (GPER/GPR30) in lung cancer. BMC Cancer 12, 624
21. Plante, B.J., Lessey, B.A., Taylor, R.N., Wang, W., Bagchi, M.K., Yuan, L., Scotchie, J., Fritz, M.A. and Young, S.L. (2012) G protein-coupled estrogen receptor (GPER) expression in normal and abnormal endometrium. Reprod. Sci. 19, 684-693
22. Lindsey, S.H., Yamaleyeva, L.M., Brosnihan, K.B., Gallagher, P.E. and Chappell, M.C. (2011) Estrogen receptor GPR30 reduces oxidative stress and proteinuria in the salt-sensitive female mRen2.Lewis rat. Hypertension 58, 665-671
23. Prossnitz, E.R. and Hathaway, H.J. (2015) What have we learned about GPER function in physiology and disease from knockout mice? J. Steroid. Biochem. Mol. Biol. 153, 114-126
24. Wang, Z., Zhang, X., Shen, P., Loggie, B.W., Chang, Y. and Deuel, T.F. (2005) Identification, cloning, and expression of human estrogen receptor-alpha 36, a novel variant of human estrogen receptor-alpha 66. Biochem. Biophys. Res. Commun. 336, 1023-1027
25. Wang, Z., Zhang, X., Shen, P., Loggie, B.W., Chang, Y. and Deuel, T.F. (2006) A variant of estrogen receptor-(alpha), hER-(alpha)36: transduction of estrogen-and antiestrogen-dependent membrane-initiated mitogenic signaling. Proc. Natl. Acad. Sci. U.S.A. 103, 9063-9068
26. Shaul, P.W. (1999) Rapid activation of endothelial nitric oxide synthase by estrogen. Steroids 64, 28-34
27. Mozaffarian, D., Benjamin, E.J., Go, A.S., Arnett, D.K., Blaha, M.J., Cushman, M., de Ferranti, S., Despres, J.P., Fullerton, H.J., Howard, V.J. et al. (2015) Heart disease and stroke statistics-2015 update: a report from the American Heart Association. Circulation 131, e29-e322
28. Maranon, R. and Reckelhoff, J.F. (2013) Sex and gender differences in control of blood pressure. Clin. Sci. (Lond) 125, 311-318
29. Haas, E., Bhattacharya, I., Brailoiu, E., Damjanovic, M., Brailoiu, G.C., Gao, X., Mueller-Guerre, L., Marjon, N.A., Gut, A., Minotti, R. et al. (2009) Regulatory role of G protein-coupled-estrogen receptor for vascular function and obesity. Circ. Res. 104, 288-291
30. Lindsey, S.H., Cohen, J.A., Brosnihan, K.B., Gallagher, P.E. and Chappell, M.C. (2009) Chronic treatment with the G protein-coupled receptor 30 agonist G-1 decreases blood pressure in ovariectomized mRen2.Lewis rats. Endocrinology 150, 3753-3758
31. Martensson, U.E., Salehi, S.A., Windahl, S., Gomez, M.F., Sward, K., Daszkiewicz-Nilsson, J., Wendt, A., Andersson, N., Hellstrand, P., Grande, P.O. et al. (2009) Deletion of the G protein-coupled receptor 30 impairs glucose tolerance, reduces bone growth, increases blood pressure, and eliminates estradiol-stimulated insulin release in female mice. Endocrinology 150, 687-698
32. Feldman, R.D., Gros, R., Ding, Q., Hussain, Y., Ban, M.R., McIntyre, A.D. and Hegele, R.A. (2014) A common hypofunctional genetic variant of GPER is associated with increased blood pressure in women. Br. J. Clin. Pharmacol. 78, 1441-1452
33. Lindsey, S.H., Carver, K.A., Prossnitz, E.R. and Chappell, M.C. (2011) Vasodilation in response to the GPR30 agonist G-1 is not different from estradiol in the mRen2.Lewis female rat. J. Cardiovasc. Pharmacol. 57, 598-603
34. Lindsey, S.H., Liu, L. and Chappell, M.C. (2014) Vasodilation by GPER in mesenteric arteries involves both endothelial nitric oxide and smooth muscle cAMP signaling. Steroids 81, 99-102
35. Broughton, B.R., Miller, A.A. and Sobey, C.G. (2010) Endothelium-dependent relaxation by G protein-coupled receptor 30 agonists in rat carotid arteries. Am. J. Physiol. Heart Circ. Physiol. 298, H1055-H1061
36. Gros, R., Ding, Q., Liu, B., Chorazyczewski, J. and Feldman, R.D. (2013) Aldosterone mediates its rapid effects in vascular endothelial cells through GPER activation. Am. J. Physiol. Cell Physiol. 304, C532-C540
37. Meyer, M.R., Baretella, O., Prossnitz, E.R. and Barton, M. (2010) Dilation of epicardial coronary arteries by the G protein-coupled estrogen receptor agonists G-1 and ICI 182,780. Pharmacology 86, 58-64
38. Yu, X., Ma, H., Barman, S.A., Liu, A.T., Sellers, M., Stallone, J.N., Prossnitz, E.R., White, R.E. and Han, G. (2011) Activation of G protein-coupled estrogen receptor induces endotheliumindependent relaxation of coronary artery smooth muscle. Am. J. Physiol. Endocrinol. Metab. 301, E882-E888
39. Reslan, O.M., Yin, Z., do Nascimento, G.R. and Khalil, R.A. (2013) Subtype-specific estrogen receptor-mediated vasodilator activity in the cephalic, thoracic, and abdominal vasculature of female rat. J. Cardiovasc. Pharmacol. 62, 26-40
40. Arefin, S., Simoncini, T., Wieland, R., Hammarqvist, F., Spina, S., Goglia, L. and Kublickiene, K. (2014) Vasodilatory effects of the selective GPER agonist G-1 is maximal in arteries of postmenopausal women. Maturitas 78, 123-130
41. Meyer, M.R., Prossnitz, E.R. and Barton, M. (2011) The G protein-coupled estrogen receptor GPER/GPR30 as a regulator of cardiovascular function. Vascul. Pharmacol. 55, 17-25
42. Meyer, M.R., Fredette, N.C., Barton, M. and Prossnitz, E.R. (2015) G protein-coupled estrogen receptor inhibits vascular prostanoid production and activity. J. Endocrinol. 227, 61-69
43. Meyer, M.R., Amann, K., Field, A.S., Hu, C., Hathaway, H.J., Kanagy, N.L., Walker, M.K., Barton, M. and Prossnitz, E.R. (2012) Deletion of G protein-coupled estrogen receptor increases endothelial vasoconstriction. Hypertension 59, 507-512
44. Meyer, M.R., Field, A.S., Kanagy, N.L., Barton, M. and Prossnitz, E.R. (2012) GPER regulates endothelin-dependent vascular tone and intracellular calcium. Life Sci. 91, 623-627
45. Ferreira, N.S., Cau, S.B., Silva, M.A., Manzato, C.P., Mestriner, F.L., Matsumoto, T., Carneiro, F.S. and Tostes, R.C. (2015) Diabetes impairs the vascular effects of aldosterone mediated by G protein-coupled estrogen receptor activation. Front. Pharmacol. 6, 34
46. Pechere-Bertschi, A. and Burnier, M. (2004) Female sex hormones, salt, and blood pressure regulation. Am. J. Hypertens. 17, 994-1001
47. Hutchens, M.P., Nakano, T., Kosaka, Y., Dunlap, J., Zhang, W., Herson, P.S., Murphy, S.J., Anderson, S. and Hurn, P.D. (2010) Estrogen is renoprotective via a nonreceptor-dependent mechanism after cardiac arrest in vivo. Anesthesiology 112, 395-405
48. Hazell, G.G., Yao, S.T., Roper, J.A., Prossnitz, E.R., O'Carroll, A.M. and Lolait, S.J. (2009) Localisation of GPR30, a novel G protein-coupled oestrogen receptor, suggests multiple functions in rodent brain and peripheral tissues. J. Endocrinol. 202, 223-236
49. Cheng, S.B., Graeber, C.T., Quinn, J.A. and Filardo, E.J. (2011) Retrograde transport of the transmembrane estrogen receptor, G-protein-coupled-receptor-30 (GPR30/GPER) from the plasma membrane towards the nucleus. Steroids 76, 892-896
50. Hutchens, M.P., Fujiyoshi, T., Komers, R., Herson, P.S. and Anderson, S. (2012) Estrogen protects renal endothelial barrier function from ischemia-reperfusion in vitro and in vivo. Am. J. Physiol. Renal. Physiol. 303, F377-F385
51. Kurt, A.H. and Buyukafsar, K. (2013) Vasoconstriction induced by G1, a G-protein-coupled oestrogen receptor 1 (GPER-1) agonist, in the isolated perfused rat kidney. Eur. J. Pharmacol. 702, 71-78
52. Adams, M.R., Kaplan, J.R., Manuck, S.B., Koritnik, D.R., Parks, J.S., Wolfe, M.S. and Clarkson, T.B. (1990) Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariectomized monkeys. Lack of an effect of added progesterone. Arteriosclerosis 10, 1051-1057
53. Kaplan, J.R., Adams, M.R., Anthony, M.S., Morgan, T.M., Manuck, S.B. and Clarkson, T.B. (1995) Dominant social status and contraceptive hormone treatment inhibit atherogenesis in premenopausal monkeys. Arterioscler. Thromb. Vasc. Biol. 15, 2094-2100
54. Hodgin, J.B., Krege, J.H., Reddick, R.L., Korach, K.S., Smithies, O. and Maeda, N. (2001) Estrogen receptor alpha is a major mediator of 17beta-estradiol's atheroprotective effects on lesion size in Apoe-/-mice. J. Clin. Invest. 107, 333-340
55. Villablanca, A.C., Tenwolde, A., Lee, M., Huck, M., Mumenthaler, S. and Rutledge, J.C. (2009) 17beta-estradiol prevents early-stage atherosclerosis in estrogen receptor-alpha deficient female mice. J. Cardiovasc. Transl. Res. 2, 289-299
56. Meyer, M.R., Fredette, N.C., Howard, T.A., Hu, C., Ramesh, C., Daniel, C., Amann, K., Arterburn, J.B., Barton, M. and Prossnitz, E.R. (2014) G protein-coupled estrogen receptor protects from atherosclerosis. Sci. Rep. 4, 7564
57. Yamaji, K., Shiomi, H., Morimoto, T., Toyota, T., Ono, K., Furukawa, Y., Nakagawa, Y., Kadota, K., Ando, K., Shirai, S. et al. (2015) Influence of sex on long-term outcomes after implantation of bare-metal stent: a multicenter report from the Coronary Revascularization Demonstrating Outcome Study-Kyoto (CREDO-Kyoto) Registry Cohort-1. Circulation 132, 2323-2333
58. Chen, S.J., Li, H., Durand, J., Oparil, S. and Chen, Y.F. (1996) Estrogen reduces myointimal proliferation after balloon injury of rat carotid artery. Circulation 93, 577-584
59. Chandrasekar, B. and Tanguay, J.F. (2000) Local delivery of 17-beta-estradiol decreases neointimal hyperplasia after coronary angioplasty in a porcine model. J. Am. Coll. Cardiol. 36, 1972-1978
60. Geraldes, P., Geoffroy, P., Cloutier, I., Sirois, M.G. and Tanguay, J.F. (2008) Local delivery of 17-beta-estradiol modulates collagen content in coronary porcine arteries after PTCA and stent implantation. J. Vasc. Res. 45, 503-511
61. Han, Y., Liang, M., Kang, J., Qi, Y., Deng, J., Xu, K. and Yan, C. (2007) Estrogen-eluting stent implantation inhibits neointimal formation and extracellular signal-regulated kinase activation. Catheter. Cardiovasc. Interv. 70, 647-653
62. New, G., Moses, J.W., Roubin, G.S., Leon, M.B., Colombo, A., Iyer, S.S., Tio, F.O., Mehran, R. and Kipshidze, N. (2002) Estrogen-eluting, phosphorylcholine-coated stent implantation is associated with reduced neointimal formation but no delay in vascular repair in aporcine coronary model. Catheter. Cardiovasc. Interv. 57, 266-271
63. Iafrati, M.D., Karas, R.H., Aronovitz, M., Kim, S., Sullivan, Jr, T.R., Lubahn, D.B., O'Donnell, Jr, T.F., Korach, K.S. and Mendelsohn, M.E. (1997) Estrogen inhibits the vascular injury response in estrogen receptor alpha-deficient mice. Nat. Med. 3, 545-548
64. Li, F., Yu, X., Szynkarski, C.K., Meng, C., Zhou, B., Barhoumi, R., White, R.E., Heaps, C.L., Stallone, J.N. and Han, G. (2013) Activation of GPER induces differentiation and inhibition of coronary artery smooth muscle cell proliferation. PLoS One 8, e64771
65. Bowling, M.R., Xing, D., Kapadia, A., Chen, Y.F., Szalai, A.J., Oparil, S. and Hage, F.G. (2014) Estrogen effects on vascular inflammation are age dependent: role of estrogen receptors. Arterioscler. Thromb. Vasc. Biol. 34, 1477-1485
66. Rettew, J.A., McCall, S.H.t. and Marriott, I. (2010) GPR30/GPER-1 mediates rapid decreases inTLR4 expression on murine macrophages. Mol. Cell Endocrinol. 328, 87-92
67. Chakrabarti, S. and Davidge, S.T. (2012) G-protein coupled receptor 30 (GPR30): a novel regulator of endothelial inflammation. PLoS One 7, e52357
68. Scantlebury, D.C. and Borlaug, B.A. (2011) Why are women more likely than men to develop heart failure with preserved ejection fraction? Curr. Opin. Cardiol. 26, 562-568
69. Douglas, P.S., Katz, S.E., Weinberg, E.O., Chen, M.H., Bishop, S.P. and Lorell, B.H. (1998) Hypertrophic remodeling: gender differences in the early response to left ventricular pressure overload. J. Am. Coll. Cardiol. 32, 1118-1125
70. Gardner, J.D., Brower, G.L. and Janicki, J.S. (2002) Gender differences in cardiac remodeling secondary to chronic volume overload. J. Card. Fail. 8, 101-107
71. Voloshenyuk, T.G. and Gardner, J.D. (2010) Estrogen improves TIMP-MMP balance and collagen distribution in volume-overloaded hearts of ovariectomized females. Am. J. Physiol. Regul. Integr. Comp. Physiol. 299, R683-R693
72. Skavdahl, M., Steenbergen, C., Clark, J., Myers, P., Demianenko, T., Mao, L., Rockman, H.A., Korach, K.S. and Murphy, E. (2005) Estrogen receptor-beta mediates male-female differences in the development of pressure overload hypertrophy. Am. J. Physiol. Heart Circ. Physiol. 288, H469-H476
73. Zhao, Z., Wang, H., Jessup, J.A., Lindsey, S.H., Chappell, M.C. and Groban, L. (2014) Role of estrogen in diastolic dysfunction. Am. J. Physiol. Heart Circ. Physiol. 306, H628-H640
74. Wang, H., Jessup, J.A., Lin, M.S., Chagas, C., Lindsey, S.H. and Groban, L. (2012) Activation of GPR30 attenuates diastolic dysfunction and left ventricle remodelling in oophorectomized mRen2.Lewis rats. Cardiovasc. Res. 94, 96-104
75. Wang, H., Zhao, Z., Lin, M. and Groban, L. (2015) Activation of GPR30 inhibits cardiac fibroblast proliferation. Mol. Cell Biochem. 405, 135-148
76. Jessup, J.A., Lindsey, S.H., Wang, H., Chappell, M.C. and Groban, L. (2010) Attenuation of salt-induced cardiac remodeling and diastolic dysfunction by the GPER agonist G-1 in female mRen2.Lewis rats. PLoS One 5, e15433
77. Bopassa, J.C., Eghbali, M., Toro, L. and Stefani, E. (2010) A novel estrogen receptor GPER inhibits mitochondria permeability transition pore opening and protects the heart against ischemia-reperfusion injury. Am. J. Physiol. Heart Circ. Physiol. 298, H16-H23
78. Deschamps, A.M. and Murphy, E. (2009) Activation of a novel estrogen receptor, GPER, is cardioprotective in male and female rats. Am. J. Physiol. Heart Circ. Physiol. 297, H1806-H1813
79. Meoli, L., Isensee, J., Zazzu, V., Nabzdyk, C.S., Soewarto, D., Witt, H., Foryst-Ludwig, A., Kintscher, U. and Noppinger, P.R. (2014) Sex-and age-dependent effects of Gpr30 genetic deletion on the metabolic and cardiovascular profiles of diet-induced obese mice. Gene 540, 210-216
80. Brailoiu, G.C., Arterburn, J.B., Oprea, T.I., Chitravanshi, V.C. and Brailoiu, E. (2013) Bradycardic effects mediated by activation of G protein-coupled estrogen receptor in rat nucleus ambiguus. Exp. Physiol. 98, 679-691
81. Zhao, Z., Wang, H., Lin, M. and Groban, L. (2015) GPR30 decreases cardiacchymase/angiotensin II by inhibiting local mast cell number. Biochem. Biophys. Res. Commun. 459, 131-136
82. Kang, S., Liu, Y., Sun, D., Zhou, C., Liu, A., Xu, C., Hao, Y., Li, D., Yan, C. and Sun, H. (2012) Chronic activation of the G protein-coupled receptor 30 with agonist G-1 attenuates heart failure. PLoS One 7, e48185
83. Otto, C., Fuchs, I., Kauselmann, G., Kern, H., Zevnik, B., Andreasen, P., Schwarz, G., Altmann, H., Klewer, M., Schoor, M. et al. (2009) GPR30 does not mediate estrogenic responses in reproductive organs in mice. Biol. Reprod. 80, 34-41
84. Isensee, J., Meoli, L., Zazzu, V., Nabzdyk, C., Witt, H., Soewarto, D., Effertz, K., Fuchs, H., Gailus-Durner, V., Busch, D. et al. (2009) Expression pattern of G protein-coupled receptor 30 in LacZ reporter mice. Endocrinology 150, 1722-1730.
85. Naugle, M.M., Nguyen, L.T., Merceron, T.K., Filardo, E., Janssen, W.G., Morrison, J.H., Rapp, P.R. and Gore, A.C. (2014) G-protein coupled estrogen receptor, estrogen receptor alpha, and progesterone receptor immunohistochemistry in the hypothalamus of aging female rhesus macaques given long-term estradiol treatment. J. Exp. Zool. A Ecol. Genet. Physiol. 321, 399-414
86. Kolkova, Z., Noskova, V., Ehinger, A., Hansson, S. and Casslen, B. (2010) G protein-coupled estrogen receptor 1 (GPER, GPR 30) in normal human endometrium and early pregnancy decidua. Mol. Hum. Reprod. 16, 743-751
87. Tian, R., Wang, Z., Shi, Z., Li, D., Wang, Y., Zhu, Y., Lin, W., Gui, Y. and Zheng, X.L. (2013) Differential expression of G-protein-coupled estrogen receptor-30 in human myometrial and uterine leiomyoma smooth muscle. Fertil. Steril. 99, 256-263
88. Windahl, S.H., Andersson, N., Chagin, A.S., Martensson, U.E., Carlsten, H., Olde, B., Swanson, C., Moverare-Skrtic, S., Savendahl, L., Lagerquist, M.K. et al. (2009) The role of theG protein-coupled receptor GPR30 in the effects of estrogen in ovariectomized mice. Am. J. Physiol. Endocrinol. Metab. 296, E490-E496
89. Gao, F., Ma, X., Ostmann, A.B. and Das, S.K. (2011) GPR30 activation opposes estrogen dependent uterine growth via inhibition of stromal ERK1/2 and estrogen receptor alpha (ERalpha) phosphorylation signals. Endocrinology 152, 1434-1447
90. Imesch, P., Samartzis, E.P., Dedes, K.J., Fink, D. and Fedier, A. (2013) Histone deacetylase inhibitors down-regulate G-protein-coupled estrogen receptor and the GPER antagonist G-15 inhibits proliferation in endometriotic cells. Fertil. Steril. 100, 770-776
91. Tica, A.A., Dun, E.C., Tica, O.S., Gao, X., Arterburn, J.B., Brailoiu, G.C., Oprea, T.I. and Brailoiu, E. (2011) G protein-coupled estrogen receptor 1-mediated effects in the rat myometrium. Am. J. Physiol. Cell Physiol. 301, C1262-C1269
92. Corcoran, J.J., Nicholson, C., Sweeney, M., Charnock, J.C., Robson, S.C., Westwood, M. and Taggart, M.J. (2014) Human uterine and placental arteries exhibit tissue-specific acute responses to 17beta-estradiol and estrogen-receptor-specific agonists. Mol. Hum. Reprod. 20, 433-441
93. Maiti, K., Paul, J.W., Read, M., Chan, E.C., Riley, S.C., Nahar, P. and Smith, R. (2011) G-1-activated membrane estrogen receptors mediate increased contractility of the human myometrium. Endocrinology 152, 2448-2455
94. Martinez-Traverso, G.B. and Pearl, C.A. (2015) Immunolocalization of G protein-coupled estrogen receptor in the rat epididymis. Reprod. Biol. Endocrinol. 13, 48
95. Oliveira, P.F., Alves, M.G., Martins, A.D., Correia, S., Bernardino, R.L., Silva, J., Barros, A., Sousa, M., Cavaco, J.E. and Socorro, S. (2014) Expression pattern of G protein-coupled receptor 30. in human seminiferous tubular cells. Gen. Comp. Endocrinol. 201, 16-20
96. Sandner, F., Welter, H., Schwarzer, J.U., Kohn, F.M., Urbanski, H.F. and Mayerhofer, A. (2014) Expression of the oestrogen receptor GPER by testicular peritubular cells is linked to sexual maturation and male fertility. Andrology 2, 695-701
97. Vaucher, L., Funaro, M.G., Mehta, A., Mielnik, A., Bolyakov, A., Prossnitz, E.R., Schlegel, P.N. and Paduch, D.A. (2014) Activation of GPER-1 estradiol receptor downregulates production of testosterone in isolated rat Leydig cells and adult human testis. PLoS One 9, e92425
98. Meyer, M.R., Clegg, D.J., Prossnitz, E.R. and Barton, M. (2011) Obesity, insulin resistance and diabetes: sex differences and role of oestrogen receptors. Acta Physiol. (Oxf) 203, 259-269
99. Ferrara, C.M., Lynch, N.A., Nicklas, B.J., Ryan, A.S. and Berman, D.M. (2002) Differences in adipose tissue metabolism between postmenopausal and perimenopausal women. J. Clin. Endocrinol. Metab. 87, 4166-4170
100. Stubbins, R.E., Najjar, K., Holcomb, V.B., Hong, J. and Nunez, N.P. (2012) Oestrogen alters adipocyte biology and protects female mice from adipocyte inflammation and insulin resistance. Diabetes Obes. Metab. 14, 58-66
101. Tiano, J.P. and Mauvais-Jarvis, F. (2012) Importance of oestrogen receptors to preserve functional beta-cell mass in diabetes. Nat. Rev. Endocrinol. 8, 342-351
102. Liu, S., Le May, C., Wong, W.P., Ward, R.D., Clegg, D.J., Marcelli, M., Korach, K.S. and Mauvais-Jarvis, F. (2009) Importance of extranuclear estrogen receptor-alpha and membrane G protein-coupled estrogen receptor in pancreatic islet survival. Diabetes 58, 2292-2302
103. Davis, K.E., Carstens, E.J., Irani, B.G., Gent, L.M., Hahner, L.M. and Clegg, D.J. (2014) Sexually dimorphic role of G protein-coupled estrogen receptor (GPER) in modulating energy homeostasis. Horm. Behav. 66, 196-207
104. Ropero, A.B., Pang, Y., Alonso-Magdalena, P., Thomas, P. and Nadal, A. (2012) Role of ERbeta and GPR30 in the endocrine pancreas: a matter of estrogen dose. Steroids 77, 951-958
105. Barton, M. and Prossnitz, E.R. (2015) Emerging roles of GPER in diabetes and atherosclerosis. Trends Endocrinol. Metab. 26, 185-192
106. Sharma, G., Hu, C., Brigman, J.L., Zhu, G., Hathaway, H.J. and Prossnitz, E.R. (2013) GPER deficiency in male mice results in insulin resistance, dyslipidemia, and aproinflammatory state. Endocrinology 154, 4136-4145
107. Balhuizen, A., Kumar, R., Amisten, S., Lundquist, I. and Salehi, A. (2010) Activation of G protein-coupled receptor 30 modulates hormone secretion and counteracts cytokine-induced apoptosis in pancreatic islets of female mice. Mol. Cell Endocrinol. 320, 16-24
108. Sharma, G. and Prossnitz, E.R. (2011) Mechanisms of estradiol-induced insulin secretion by theG protein-coupled estrogen receptor GPR30/GPER in pancreatic beta-cells. Endocrinology 152, 3030-3039
109. Shapiro, A.M. (2012) Islet transplantation in type 1 diabetes: ongoing challenges, refined procedures, and long-term outcome. Rev. Diabet. Stud. 9, 385-406
110. Liu, S., Kilic, G., Meyers, M.S., Navarro, G., Wang, Y., Oberholzer, J. and Mauvais-Jarvis, F. (2013) Oestrogens improve human pancreatic islet transplantation in a mouse model of insulin deficient diabetes. Diabetologia 56, 370-381
111. Albanito, L., Madeo, A., Lappano, R., Vivacqua, A., Rago, V., Carpino, A., Oprea, T.I., Prossnitz, E.R., Musti, A.M., Ando, S. et al. (2007) G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells. Cancer Res. 67, 1859-1866
112. Wei, W., Chen, Z.J., Zhang, K.S., Yang, X.L., Wu, Y.M., Chen, X.H., Huang, H.B., Liu, H.L., Cai, S.H., Du, J. et al. (2014) The activation of G protein-coupled receptor 30 (GPR30) inhibits proliferation of estrogen receptor-negative breast cancer cells in vitro and in vivo. Cell Death Dis. 5, e1428
113. Ariazi, E.A., Brailoiu, E., Yerrum, S., Shupp, H.A., Slifker, M.J., Cunliffe, H.E., Black, M.A., Donato, A.L., Arterburn, J.B., Oprea, T.I. et al. (2010) The G protein-coupled receptor GPR30 inhibits proliferation of estrogen receptor-positive breast cancer cells. Cancer Res. 70, 1184-1194
114. Chan, Q.K., Lam, H.M., Ng, C.F., Lee, A.Y., Chan, E.S., Ng, H.K., Ho, S.M. and Lau, K.M. (2010) Activation of GPR30 inhibits the growth of prostate cancer cells through sustained activation of Erk1/2, c-jun/c-fos-dependent upregulation of p21, and induction of G(2) cell cycle arrest. Cell Death Differ. 17, 1511-1523
115. Zhang, Z., Duan, L., Du, X., Ma, H., Park, I., Lee, C., Zhang, J. and Shi, J. (2008) The proliferative effect of estradiol on human prostate stromal cells is mediated through activation of ERK. Prostate 68, 508-516
116. Vivacqua, A., De Marco, P., Santolla, M.F., Cirillo, F., Pellegrino, M., Panno, M.L., Abonante, S. and Maggiolini, M. (2015) Estrogenic gper signaling regulates mir144 expression in cancer cells and cancer-associated fibroblasts (cafs). Oncotarget 6, 16573-16587
117. Recchia, A.G., De Francesco, E.M., Vivacqua, A., Sisci, D., Panno, M.L., Ando, S. and Maggiolini, M. (2011) The G protein-coupled receptor 30 is up-regulated by hypoxia-inducible-factor-1alpha (HIF-1alpha) in breast cancer cells and cardiomyocytes. J. Biol. Chem. 286, 10773-10782
118. Lappano, R., Rigiracciolo, D., De Marco, P., Avino, S., Cappello, A.R., Rosano, C., Maggiolini, M. and De Francesco, E.M. (2016) Recent advances on the role of G protein-coupled receptors in hypoxia-mediated signaling. AAPS J. 18, 305-310
119. Holm, A., Grande, P.O., Luduena, R.F., Olde, B., Prasad, V., Leeb-Lundberg, L.M. and Nilsson, B.O. (2012) The G protein-coupled oestrogen receptor 1 agonist G-1 disrupts endothelial cell microtubule structure in a receptor-independent manner. Mol. Cell Biochem. 366, 239-249
120. Rigiracciolo, D.C., Scarpelli, A., Lappano, R., Pisano, A., Santolla, M.F., De Marco, P., Cirillo, F., Cappello, A.R., Dolce, V., Belfiore, A. et al. (2015) Copper activates HIF-1alpha/GPER/VEGF signalling in cancer cells. Oncotarget 6, 34158-34177
121. Lappano, R., Pisano, A. and Maggiolini, M. (2014) GPER function in breast cancer: an overview. Front. Endocrinol. (Lausanne) 5, 66
122. Arias-Pulido, H., Royce, M., Gong, Y., Joste, N., Lomo, L., Lee, S.J., Chaher, N., Verschraegen, C., Lara, J., Prossnitz, E.R. et al. (2010) GPR30 and estrogen receptor expression: new insights into hormone dependence of inflammatory breast cancer. Breast Cancer Res. Treat. 123, 51-58
123. Ignatov, T., Weissenborn, C., Poehlmann, A., Lemke, A., Semczuk, A., Roessner, A., Costa, S.D., Kalinski, T. and Ignatov, A. (2013) GPER-1 expression decreases during breast cancer tumorigenesis. Cancer Invest. 31, 309-315
124. Lumachi, F., Santeufemia, D.A. and Basso, S.M. (2015) Current medical treatment of estrogen receptor-positive breast cancer. World J. Biol. Chem. 6, 231-239
125. Viedma-Rodriguez, R., Baiza-Gutman, L., Salamanca-Gomez, F., Diaz-Zaragoza, M., Martinez-Hernandez, G., Ruiz Esparza-Garrido, R., Velazquez-Flores, M.A. and Arenas-Aranda, D. (2014) Mechanisms associated with resistance to tamoxifen in estrogen receptor-positive breast cancer (review). Oncol. Rep. 32, 3-15
126. Ignatov, A., Ignatov, T., Roessner, A., Costa, S.D. and Kalinski, T. (2010) Role of GPR30 in the mechanisms of tamoxifen resistance in breast cancer MCF-7 cells. Breast Cancer Res. Treat. 123, 87-96
127. Catalano, S., Giordano, C., Panza, S., Chemi, F., Bonofiglio, D., Lanzino, M., Rizza, P., Romeo, F., Fuqua, S.A., Maggiolini, M. et al. (2014) Tamoxifen through GPER upregulates aromatase expression: a novel mechanism sustaining tamoxifen-resistant breast cancer cell growth. Breast Cancer Res. Treat. 146, 273-285
128. Nass, N. and Kalinski, T. (2015) Tamoxifen resistance: from cell culture experiments towards novel biomarkers. Pathol. Res. Pract. 211, 189-197
129. Thomas, P. and Dong, J. (2006) Binding and activation of the seven-transmembrane estrogen receptor GPR30 by environmental estrogens: a potential novel mechanism of endocrine disruption. J. Steroid. Biochem. Mol. Biol. 102, 175-179
130. Prossnitz, E.R. and Barton, M. (2014) Estrogen biology: new insights into GPER function and clinical opportunities. Mol. Cell Endocrinol. 389, 71-83
131. Vandenberg, L.N., Chahoud, I., Heindel, J.J., Padmanabhan, V., Paumgartten, F.J. and Schoenfelder, G. (2010) Urinary, circulating, and tissue biomonitoring studies indicate widespread exposure to bisphenol A. Environ. Health Perspect. 118, 1055-1070
132. Ge, L.C., Chen, Z.J., Liu, H.Y., Zhang, K.S., Liu, H., Huang, H.B., Zhang, G., Wong, C.K., Giesy, J.P., Du, J. et al. (2014) Involvement of activating ERK1/2 through G protein coupled-receptor 30 and estrogen receptor alpha/beta in low doses of bisphenol A promoting growth of Sertoli TM4 cells. Toxicol. Lett. 226, 81-89
133. Sheng, Z.G., Huang, W., Liu, Y.X. and Zhu, B.Z. (2013) Bisphenol A at a low concentration boosts mouse spermatogonial cell proliferation by inducing the G protein-coupled receptor 30 expression. Toxicol. Appl. Pharmacol. 267, 88-94
134. Sheng, Z.G. and Zhu, B.Z. (2011) Low concentrations of bisphenol A induce mouse spermatogonial cell proliferation by G protein-coupled receptor 30 and estrogen receptor-alpha. Environ. Health Perspect. 119, 1775-1780
135. Kajta, M., Litwa, E., Rzemieniec, J., Wnuk, A., Lason, W., Zelek-Molik, A., Nalepa, I., Grzegorzewska-Hiczwa, M., Tokarski, K., Golas, A. et al. (2014) Isomer-nonspecific action of dichlorodiphenyl trichloroethane on aryl hydrocarbon receptor and G-protein coupled-receptor 30 intracellular signaling in apoptotic neuronal cells. Mol. Cell Endocrinol. 392, 90-105
136. Schmidt, S., Degen, G.H., Seibel, J., Hertrampf, T., Vollmer, G. and Diel, P. (2006) Hormonal activityof combinations of genistein, bisphenol A and 17beta-estradiol in the female Wistar rat. Arch. Toxicol. 80, 839-845
137. Luo, L.J., Liu, F., Lin, Z.K., Xie, Y.F., Xu, J.L., Tong, Q.C. and Shu, R. (2012) Genistein regulates the IL-1beta induced activation of MAPKs in human periodontal ligament cells through G protein-coupled receptor 30. Arch. Biochem. Biophys. 522, 9-16
138. Albanito, L., Lappano, R., Madeo, A., Chimento, A., Prossnitz, E.R., Cappello, A.R., Dolce, V., Abonante, S., Pezzi, V. and Maggiolini, M. (2015) Effects of atrazine on estrogen receptor alpha-and G protein-coupled receptor 30-mediated signaling and proliferation in cancer cells and cancer-associated fibroblasts. Environ. Health Perspect. 123, 493-499
139. Yu, X., Filardo, E.J. and Shaikh, Z.A. (2010) The membrane estrogen receptor GPR30 mediates cadmium-induced proliferation of breast cancer cells. Toxicol. Appl. Pharmacol. 245, 83-90
140. Zhang, K.S., Chen, H.Q., Chen, Y.S., Qiu, K.F., Zheng, X.B., Li, G.C., Yang, H.D. and Wen, C.J. (2014) Bisphenol A stimulates human lung cancer cell migration via upregulation of matrix metalloproteinases by GPER/EGFR/ERK1/2 signal pathway. Biomed. Pharmacother. 68, 1037-1043
141. Petrie, W.K., Dennis, M.K., Hu, C., Dai, D., Arterburn, J.B., Smith, H.O., Hathaway, H.J. and Prossnitz, E.R. (2013) G protein-coupled estrogen receptor-selective ligands modulate endometrial tumor growth. Obstet. Gynecol. Int. 2013, 472720
142. Ma, H.R., Wang, J., Chen, Y.F., Chen, H., Wang, W.S. and Aisa, H.A. (2014) Icariin and icaritin stimulate the proliferation of SKBr3 cells through the GPER1-mediated modulation of the EGFR-MAPK signaling pathway. Int. J. Mol. Med. 33, 1627-1634
143. Gao, Q., Liu, S., Guo, F., Liu, S., Yu, X., Hu, H., Sun, X., Hao, L. and Zhu, T. (2015) Nonylphenol affects myocardial contractility and L-type Ca(2+) channel currents in a non-monotonic manner via G protein-coupled receptor 30. Toxicology 334, 122-129
144. Belcher, S.M., Gear, R.B. and Kendig, E.L. (2015) Bisphenol A alters autonomic tone and extracellular matrix structure and induces sex-specific effects on cardiovascular function in male and female CD-1 mice. Endocrinology 156, 882-895
145. Contreras, I. and Parra, D. (2000) Estrogen replacement therapy and the prevention of coronary heart disease in postmenopausal women. Am. J. Health Syst. Pharm. 57, 1963-1968
146. Rossouw, J.E., Anderson, G.L., Prentice, R.L., LaCroix, A.Z., Kooperberg, C., Stefanick, M.L., Jackson, R.D., Beresford, S.A., Howard, B.V., Johnson, K.C. et al. (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288, 321-333
147. Anderson, G.L., Limacher, M., Assaf, A.R., Bassford, T., Beresford, S.A., Black, H., Bonds, D., Brunner, R., Brzyski, R., Caan, B. et al. (2004) Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 291, 1701-1712
148. Hulley, S.B. and Grady, D. (2004) The WHI estrogen-alone trial-do things look any better? JAMA 291, 1769-1771
149. Rossouw, J.E., Prentice, R.L., Manson, J.E., Wu, L., Barad, D., Barnabei, V.M., Ko, M., LaCroix, A.Z., Margolis, K.L. and Stefanick, M.L. (2007) Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 297, 1465-1477
150. Hersh, A.L., Stefanick, M.L. and Stafford, R.S. (2004) National use of postmenopausal hormone therapy: annual trends and response to recent evidence. JAMA 291, 47-53
151. Grady, D., Gebretsadik, T., Kerlikowske, K., Ernster, V. and Petitti, D. (1995) Hormone replacement therapy and endometrial cancer risk: a meta-analysis. Obstet. Gynecol. 85, 304-313
152. Kharode, Y., Bodine, P.V., Miller, C.P., Lyttle, C.R. and Komm, B.S. (2008) The pairing of a selective estrogen receptor modulator, bazedoxifene, with conjugated estrogens as a new paradigm for the treatment of menopausal symptoms and osteoporosis prevention. Endocrinology 149, 6084-6091
153. Broughton, B.R., Brait, V.H., Kim, H.A., Lee, S., Chu, H.X., Gardiner-Mann, C.V., Guida, E., Evans, M.A., Miller, A.A., Arumugam, T.V. et al. (2014) Sex-dependent effects of G protein coupled estrogen receptor activity on outcome after ischemic stroke. Stroke 45, 835-841
154. Revankar, C.M., Mitchell, H.D., Field, A.S., Burai, R., Corona, C., Ramesh, C., Sklar, L.A., Arterburn, J.B. and Prossnitz, E.R. (2007) Synthetic estrogen derivatives demonstrate the functionality of intracellular GPR30. ACS Chem. Biol. 2, 536-544
155. Pupo, M., Vivacqua, A., Perrotta, I., Pisano, A., Aquila, S., Abonante, S., Gasperi-Campani, A., Pezzi, V. and Maggiolini, M. (2013) The nuclear localization signal is required for nuclear GPER translocation and function in breast Cancer-Associated Fibroblasts (CAFs). Mol. Cell Endocrinol. 376, 23-32
156. Samartzis, E.P., Noske, A., Meisel, A., Varga, Z., Fink, D. and Imesch, P. (2014) The G protein coupled estrogen receptor (GPER) is expressed in two different subcellular localizations reflecting distinct tumor properties in breast cancer. PLoS One 9, e83296
157. Kumar, R., Balhuizen, A., Amisten, S., Lundquist, I. and Salehi, A. (2011) Insulinotropic and antidiabetic effects of 17beta-estradiol and the GPR30 agonist G-1 on human pancreatic islets. Endocrinology 152, 2568-2579
158. Broselid, S., Berg, K.A., Chavera, T.A., Kahn, R., Clarke, W.P., Olde, B. and Leeb-Lundberg, L.M. (2014) G protein-coupled receptor 30 (GPR30) forms a plasma membrane complex with membrane-associated guanylate kinases (MAGUKs) and protein kinase Aanchoringprotein 5 (AKAP5) that constitutively inhibits cAMP production. J. Biol. Chem. 289, 22117-22127
159. Qiu, J., Ronnekleiv, O.K. and Kelly, M.J. (2008) Modulation of hypothalamic neuronal activity through a novel G-protein-coupled estrogen membrane receptor. Steroids 73, 985-991
160. Feldman, R.D. and Limbird, L.E. (2015) Copernicus revisited: overturning Ptolemy's view of the GPER universe. Trends Endocrinol. Metab. 26, 592-594